Literature DB >> 27314681

Disseminated intravascular coagulation - new pathophysiological concepts and impact on management.

Jecko Thachil1.   

Abstract

INTRODUCTION: Disseminated intravascular coagulation (DIC) is an intermediary mechanism of disease which develops secondary to many causes including sepsis, trauma and malignancies. This review attempts to summarise the new pathophysiological developments and the impact they have on the current and future management of DIC. AREAS COVERED: Several publications detailing the pathophysiology of DIC and the clinical management were identified using a pubmed search. Expert commentary: In recent years, on the initiatives of the international society of thrombosis and haemostasis, important advances have been made on the diagnostic aspect of DIC. In addition, several researchers have focused on the pathophysiology of the condition which is likely to provide better diagnostic markers and targeted therapy. However, some confusion still exists in the definition and management of DIC since various specialists understands the mechanisms involved in DIC from different perspectives.

Entities:  

Keywords:  Platelets; anticoagulation; coagulation; disseminated intravascular coagulation; histones

Mesh:

Substances:

Year:  2016        PMID: 27314681     DOI: 10.1080/17474086.2016.1203250

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  9 in total

1.  Postoperative thrombotic effects of tranexamic acid in open heart surgery.

Authors:  Ayten Saracoglu; Mehmet Ezelsoy; Kemal Tolga Saracoglu
Journal:  Ir J Med Sci       Date:  2019-02-28       Impact factor: 1.568

Review 2.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

3.  Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study.

Authors:  Simon Flæng; Søren Nygaard; Asger Granfeldt; Anne-Mette Hvas; Henrik Toft Sørensen; Jecko Thachil; Kasper Adelborg
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

Review 4.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

5.  Repeat dose exposure of PM2.5 triggers the disseminated intravascular coagulation (DIC) in SD rats.

Authors:  Shuang Liang; Tong Zhao; Hejing Hu; Yanfeng Shi; Qing Xu; Mark R Miller; Junchao Duan; Zhiwei Sun
Journal:  Sci Total Environ       Date:  2019-01-28       Impact factor: 7.963

6.  Effect of disseminated intravascular coagulation on donation after citizens' death donor kidneys.

Authors:  Lu Xu; Wei Yin; Guanghui Li; Jiali Fang; Lei Zhang; Luhao Liu; Yunyi Xiong; Jialin Wu; Guanghui Pan; Junjie Ma; Zheng Chen
Journal:  Transl Androl Urol       Date:  2021-03

7.  Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.

Authors:  Qi-Yun Zhang; Jing Guo; Lin Xu; Ying Wei; Shu-Ting Zhou; Qing-Yu Lu; Li Guo; Qian-Yun Sun
Journal:  BMC Complement Med Ther       Date:  2022-09-20

8.  Pathogenesis of hemorrhagic disease caused by elephant endotheliotropic herpesvirus (EEHV) in Asian elephants (Elephas maximus).

Authors:  Thunyamas Guntawang; Tidaratt Sittisak; Varankpicha Kochagul; Saralee Srivorakul; Kornravee Photichai; Kittikorn Boonsri; Thittaya Janyamethakul; Khajohnpat Boonprasert; Warangkhana Langkaphin; Chatchote Thitaram; Kidsadagon Pringproa
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  Tetrahydropalmatine has a therapeutic effect in a lipopolysaccharide-induced disseminated intravascular coagulation model.

Authors:  Lin Zhi; Shangqi Yang; Jiekun Chen; Yuli Lu; Jiahong Chen; Zixi Qin; Xiao-Mei Tang
Journal:  J Int Med Res       Date:  2019-12-12       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.